Raymond N. DuBois (Ray), M.D., Ph.D., is Dean of the College of Medicine at the Medical University of South Carolina, a Distinguished University Professor and Director of the Hollings Cancer Center. Prior to serving in these roles, he was Executive Director of the Biodesign Institute in Arizona (ASU) with a joint appointment as Professor of Medicine in the Mayo College of Medicine, Arizona. From 2007 to 2012, he was Provost and Executive Vice President at the University of Texas MD Anderson Cancer Center. During his tenure at Vanderbilt University Medical Center (1991-2007) he served as Director of Gastroenterology, Hepatology & Nutrition as well as Director of the Vanderbilt-Ingram Cancer Center. In 2015 he was honored by inclusion as an honorary member in the Tinsley Harrison Medical Society at Vanderbilt.

Dr. DuBois is an internationally renowned expert known for his work elucidating the role of inflammation and inflammatory mediators in the progression of colon cancer. His work and other studies led to a better understanding of the molecular basis for anti-inflammatory agents, like aspirin, in reducing cancer risk. His studies also led to clinical trials, showing how drugs that inhibit this pathway could prevent or intercept the process of the development of some types of cancer.

Dr. DuBois is a member of the National Academy of Medicine, a Fellow of the American Association for the Advancement of Science (AAAS), the Academy of the American Association for Cancer Research (AACR), the American Gastroenterology Association (AGA) and the Royal College of Physicians (London). In 2019, he was selected for the AACR Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research.

Other major awards for his cancer prevention research include the Richard and Hinda Rosenthal Research Award, the Dorothy P. Landon-AACR Cancer Prize and the Anthony Dipple Carcinogenesis Award from Oxford University Press. He is also a past president of the AACR, the Southern Society for Clinical Investigation, and the International Society for Gastrointestinal Cancer. In 2018, he was named to the steering committee for the AACR Academy, and selected as a Vice Chair for the Stand Up to Cancer (SU2C) Scientific Advisory Board. He is also a member of the American Clinical and Climatological Association, the Association of American Physicians and the American Society for Clinical Investigation. Dr. DuBois continues to serve as an editor-in-chief for Cancer Prevention Research, published by AACR. He also Chairs the Board of Scientific Counselors (Clinical & Epidemiologic Studies) for the National Cancer Institute in Bethesda, MD, the scientific board for the German National Cancer Institute (DKFZ) in Heidelberg as well as the advisory board for the German National Center for Tumor diseases (NCT).

During his career as a physician-scientist, he has published over 160 peer reviewed research articles, more than 60 review articles, 25 book chapters, and three books. His work has been cited over 60,000 times with an H-index of 111 according to Google Scholar. He is also a co-inventor of a method to identify and target cellular genes needed for viral growth as well as cellular genes that function as tumor suppressors in mammals.

Dr. DuBois earned a bachelor’s degree (Biochemistry w/honors) from Texas A&M University (College Station) and a Ph.D. (Biochemistry) from The University of Texas Southwestern Medical Center (Dallas). He obtained a medical degree from The University of Texas School of Medicine (San Antonio), followed by completion of an Osler Medicine internship/residency, and a gastroenterology fellowship at the Johns Hopkins Hospital in Baltimore. While at Hopkins he studied under Nobel Laureate Daniel Nathans as a Howard Hughes Research Associate. In 2007 he was honored by Johns Hopkins University by being inducted into the Hopkins University Society of Scholars.